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Kisspeptin  in  the  medial  amygdala  and  sexual  behavior  in  male  rats
Rebecca  Gresham,  Shengyun  Li,  Daniel  A  Adekunbi,  Minghan  Hu,  Xiao  Feng  Li,
Kevin  T  O’Byrne ∗
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h  i  g  h  l  i  g  h  t  s
• Kisspeptin  in  the  posterodorsal  medial  amygdala  evokes  ex-copular  erections  in  rats.
• The  mechanism  is  kisspeptin  receptor  speciﬁc.
• Kisspeptin  induced  GnRH  and  LH  release  are  not  implicated.
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a  b  s  t  r  a  c  t
The  medial  amygdala  (MeA)  is  crucial  for sexual  behavior;  kisspeptin  (Kiss1)  also  plays  a role  in  sexual
function.  Kisspeptin  receptor  (Kiss1r)  knockout  mice  display  no  sexual  behavior.  Recently  Kiss1  and  Kiss1r
have  been  discovered  in  the posterodorsal  subnucleus  of  the  medial  amygdala  (MePD).  We hypothesised
that  Kiss1  in the  MePD  may  have  an inﬂuence  on male  sexual  behavior.  To  test this  we  bilaterally  cannu-
lated  the  MePD  and  infused  kisspeptin-10  in  male  rats.  This  caused  the  rats  to have  multiple  erections,
an  effect  speciﬁc  to  Kiss1  receptor  activation,  because  Kiss1r  antagonism  blocked  the  erectile  response.
When  Kiss1  was  infused  into  the  lateral  cerebroventricle,  there  were  no  observed  erections.  We  also
measured  the  plasma  levels  of  LH  when  Kiss1  is infused  into  the MePD  or lateral  cerebroventricle;  Kiss1
increased  plasma  LH  to  comparable  levels  when  infused  into  both  sites.  We  conclude  that  Kiss1  has  a
role  in  male sexual  behavior,  which  is speciﬁc  to  the MePD.
©  2016  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BY
license  (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The medial amygdala (MeA) is a key brain region in sexual
behavior. Lesions of the MeA  suppress sexual behavior [1] and the
extent of lesion correlates with the decrease in sexual behavior [2].
Chemosignals from estrous females stimulate non-contact erec-
tions (NCE) and MeA  lesions also prevent these erections in male
rats [3]. Chemosignals from estrous females activate the MeA  in
male hamsters, as seen by Fos expression [4]. Androgen receptors
are found in the MeA, and testosterone or dihydrotestosterone are
required for NCE stimulated by an estrous female [5] and blocking of
androgen receptors in the MeA  prevents NCE [6]. Administration of
androgens directly into the posterodorsal subnucleus of the medial
amygdala (MePD) does not cause spontaneous erection, without
the presence of an estrous female [7] therefore, the MePD may  be
∗ Corresponding author at: Division of Women’s Health, 2.92W, Hodgkin Building,
Faculty of Life Sciences & Medicine, King’s College London, Guy’s Campus, London,
SE1 1UL, UK.
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responsible for causing erections when activated by olfactory cues
or chemosignals. In addition, impairment in erectile competence
as a result of MeA  lesion particularly for NCE is suggestive of the
importance of the MeA  on erectile function [3]. Ex-copula erections,
those that occur without an olfactory stimulus, or NCE have been
described as analogous to human psychogenic erections caused by
erotica [8].
Kisspeptin (Kiss1) and its link to sexual function have been well
studied in the anteroventral periventricular nucleus and the arcu-
ate nucleus. Kiss1 and its receptor (Kiss1r) are crucial for normal
reproductive function [9] and have recently been found within the
MePD, but their role in sexual function in this area has not been
explored [10,11]. Kiss1r knockout male mice display no sexual
behavior unless stimulated with testosterone [12], and even with
testosterone the mice do not have a partner preference; they cannot
decipher the chemosignals. Intracerebroventricular (ICV) admin-
istration of kisspeptin-10 (kp-10) in male rats dose-dependently
increases plasma luteinising hormone (LH) and testosterone [13].
In men, intravenous infusion of kp-54 stimulates LH and testos-
terone secretion [14]. Long-term infusion of kp-54 can reactivate
the photo-inhibited hypothalamic–pituitary–gonadal (HPG) axis
http://dx.doi.org/10.1016/j.neulet.2016.05.042
0304-3940/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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by direct stimulation of gonadotropin-releasing hormone (GnRH)
release in male hamsters [15].
We  hypothesised that Kiss1 is involved in the MePD inﬂuence
on male sexual behavior. To test this we infused kp-10, and its
antagonist, directly into the MePD to examine the effect on male
sexual behavior, speciﬁcally ex-copula erections, and to determine
whether GnRH/LH is involved.‘
2. Materials and methods
2.1. Animals
Adult male (200–225 g) Sprague Dawley rats obtained from
Charles River (Margate, UK) were individually housed under con-
trolled conditions (12 h light, 12 h dark cycle, lights on at 0700 h:
temperature 22 ± 2 ◦C) and supplied with food and water ad libi-
tum. Before the animals underwent surgery they were given sexual
experience, which involved housing the male with a normal cycling
adult female for 1 week. All procedures were conducted in accor-
dance with the United Kingdom Home Ofﬁce Animals Scientiﬁc
Procedures Act 1986.
2.2. Surgical procedures
Surgical procedures were performed under aseptic condi-
tions, using general anesthesia—ketamine hydrochloride USP
(100 mg/kg; Phizer Ltd., Kent, UK) and Rompun (10 mg/kg; Bayer
AG, Leverkusen, Germany) via intraperitoneal injection. The ani-
mals (n = 30) were secured in a David Kopf stereotaxic frame
(Tujunga, CA, USA) and ﬁtted with bilateral guide cannulae (22
gauge; Plastics One, Roanoke, VA) directed toward the MePD for
microinfusion of kp-10; the stereotaxic coordinates for implanta-
tion being 3.4 mm lateral, 3.14 mm posterior to bregma, and 8.6 mm
below the surface of the dura according to the rat brain atlas of
Paxinos and Watson [16]. A separate group of rats (n = 14) was
implanted with unilateral guide cannula (22 gauge; Plastics One)
directed at the left lateral cerebral ventricle for microinfusion of
kp-10; the stereotaxic coordinates for implantation were 1.5 mm
lateral, 0.6 mm posterior to bregma, and 4.0 mm below the sur-
face of the dura according to the rat brain atlas of Paxinos and
Watson [16]. These animals served as an additional control group
for potential intra-MePD administered kp-10 leaking into the ven-
tricular system to exert its effects on erectile function. The guide
cannulae were secured using dental cement (Associated Dental
Product, Swindon, UK) and ﬁtted with dummy  cannulae (Plastics
One) to maintain patency. A stainless steel slotted screw (Instec
Laboratories, Boulder, CO) was afﬁxed to the surface of the skull
posterior to the guide cannulae using dental cement. The rats were
housed singly in a male only room and allowed 3 days of recovery
before behavioral testing. Once behavioral testing was  complete
each rat was ﬁtted with two indwelling cardiac catheters via the
jugular veins, to facilitate serial blood sampling [17]. The catheters
were exteriorized at the back of the head and enclosed within
a 30-cm metal spring tether (Instec Laboratories) secured to the
slotted screw. The distal end of the tether was attached to a ﬂuid
swivel (Instec Laboratories), which allowed the rat freedom to
move around the enclosure. Experimentation commenced 3 days
later. Correct cannula placement in the MePD was conﬁrmed by
microscopic inspection of 30 m brain sections. Only data from
animals with correct cannula placement were analyzed.
2.3. Ex-copula behavioural test
The ex-copula behavioral test was performed as described by
Sach and colleagues [8]. The test arena was a Plexiglass cage
(60 × 36 × 20 cm,  with wood chip bedding, Techniplast, Italy). After
5 min  habituation to the test arena, male rats were given bilat-
eral intra-MePD injections of human kp-10 (10 pmol, 100 pmol or
1 nmol in 400 nl; Sigma-Aldrich, Poole, UK), or Kiss1r antagonist
(Peptide-234; 5 nmol in 400 nl; Sigma-Aldrich) followed by kp-
10 (1 nmol in 400 nl) 5 min  later, Peptide-234 (5 nmol in 400 nl)
or artiﬁcial cerebrospinal ﬂuid (aCSF, 400 nl) as vehicle control
over a 5 min  period. Microinfusion was performed manually over
5 min  for each drug using a 5 l syringe (Hamilton, Bonaduz,
Switzerland). For animals implanted with intracerebroventricu-
lar (ICV) cannulae, kp-10 (0.1, 1, or 5 nmol in 400 nl aCSF) was
injected over 5 min  as described above. The animals were observed
for 30 min  and the number of ex-copula erection was scored by
the emergence of glans penis from the penile sheath and intensive
penile grooming [8]. In preliminary studies, animals were observed
for 2 h; however, no erections occurred after the ﬁrst 30 min. A
crossover design was used for treatments, with each animal being
used on up to 3 occasions with a different dose on each occasion
and a 1–3 day interval between treatments. All experiments started
between 0900 and 1200 h.
2.4. Intra-MePD administration of kp-10 and kiss1r antagonist
on LH secretion
On the morning of experimentation, intra-MePD injection can-
nulae were loaded with kp-10 as above; the distal end of the tubing,
preﬁlled with aCSF was extended outside of the cage to allow
remote microinfusion without disturbing the rat during the exper-
iment. Microinfusion was performed manually over 5 min using
a 5 l syringe (Hamilton). One of the two cardiac catheters was
then attached via the ﬂuid swivel to a computer-controlled auto-
mated blood-sampling system, which allows for the intermittent
withdrawal of small blood samples (25 l) every 5 min  for 6 h with-
out disturbing the rats [18]. Once connected, the animals were left
undisturbed for 1 h before sampling commenced between 1000 and
1100 h. After removal of each 25 l blood sample, an equal volume
of heparinised saline (50 U/ml normal saline; Wockhardt, Wrex-
ham, UK) was  automatically infused into the animal to maintain
patency of the catheter and blood volume. After 2 h controlled blood
sampling, kp-10, Peptide-234 or vehicle was  infused intra-MePD
over 5 min. Rats received a single dose of 100 pmol or 1 nmol kp-10
in 400 nl aCSF, bilaterally. Control rats received 400 nl aCSF. Blood
sampling continued for further 4 h and samples were frozen at
−20 ◦C until assayed for LH. For experiments involving ICV admin-
istration of kp-10, a single dose of 1 nmol in 400 nl aCSF was  used,
and blood sampling carried as described above.
2.5. LH assay
A double-antibody RIA supplied by the National Institute of Dia-
betes and Digestive and Kidney Diseases (Bethesda, MD)  was used
to determine LH concentrations in the 25 l whole-blood samples.
The sensitivity of the assay was  0.093 ng/ml. The intra-assay varia-
tion was 7.3%, and the inter-assay variation was 10%.
2.6. LH secretion analysis
The effect of pharmacological agents on overall LH secretion was
calculated by comparing the area under the LH proﬁle [area under
the curve (AUC)] for the 2 h pre-treatment period with the 1st and
2nd 2-h post treatment periods using SigmaPlot version 13 (Sys-
tat Software, San Jose, CA). Statistical signiﬁcance was  tested using
one-way ANOVA followed by Dunnett’s test. All data were shown
as mean ± SEM. P < 0.05 was  considered statistically signiﬁcant.
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Fig. 1. Schematic illustrations and photomicrograph of the cannulae target sites in the posterodorsal medial amygdala (MePD). A, Schematic illustration showing the target
site  for bilateral cannulation of the MePD at bregma (AP) −3.14 mm,  mediolateral (ML) ± 3.4 mm and dorsoventral (DV) −8.6 mm according to the rat brain atlas of Paxinos
and  Watson [16]. Arrows point to the location of the cannulae tips. B, Photomicrograph of a coronal brain section in a representative animal implanted with bilateral cannulae
in  the MePD. 3 V, third ventricle.
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Fig. 2. Effect of kisspeptin with or without kisspeptin antagonist injection into the
posterodorsal medial amygdala (MePD) on the incidence of ex-copula erections.
Bilateral administration of 0.1 nmol kisspeptin-10 (kp-10, n = 5) into the MePD had
no  effect on the incidence of ex-copula erections. However, 1 nmol kp-10 (n = 12)
signiﬁcantly increased the number of erections experienced, an effect blocked by
kisspeptin receptor antagonism (P-234, 5 nmol; n = 6). Intra-MePD administration of
artiﬁcial cerebrospinal ﬂuid (aCSF) was withour effect (n = 12). *p < 0.05, compared
with other treatment groups. #p < 0.05, compared with 1 nmol kp-10 alone. Data
presesented as mean and SEM.
3. Results
3.1. Behavioural response to kp-10 infusion into the MePD
Out of 30 rats, 22 with correct placement of bilateral cannulae
in the MePD were veriﬁed by histological analysis with reference to
the atlas of Paxinos and Watson [16] and included in the analysis.
A representative example is shown in Fig. 1.
An intra-MePD infusion of 1 nmol kp-10 caused a signiﬁcant
increase in the number of ex-copula erections compared with aCSF
infusion (Fig. 2). All erections occurred between 8 and 27 min  after
infusion. The use of the Kiss1r antagonist, Peptide-234, prevented
the erections (Fig. 2). These ex-copula erections were not observed
with a 10 pmol (data not shown) or 100 pmol infusion of kp-10
(Fig. 2). There were no observed erections with 0.1, 1, or 5 nmol ICV
infusions of kp-10 compared with aCSF controls (n = 5–8 per group)
(data not shown). All animals implanted with ICV cannulae were
correctly placed.
3.2. LH response to kp-10 infusion into the MePD
Kp-10 dose-dependently increased plasma levels of LH in the
ﬁrst h after MePD infusion (Fig. 3), peaking at approximately 80 min
post infusion for 1 nmol of kp-10. The Kiss1r antagonist had no
effect on plasma LH (Fig. 3). An increase in plasma levels of LH
was also seen 1 h post ICV infusion of 1 nmol kp-10, reaching com-
parable levels to those observed with intra-MePD of 1 nmol kp-10.
ICV infusion of aCSF did not affect LH secretion (n = 5–8 per group)
(data not shown).
4. Discussion
Intra-MePD infusion of 1 nmol kp-10 caused multiple ex-copula
erections. The lower dose of 0.1 nmol kp-10 did not evoke an erec-
tile response indicating that a dose threshold has to be reached
to cause an erection. The erections were also blocked by Kiss1r
antagonism indicating that the response is speciﬁc to Kiss1, and
therefore may  be a prerequisite for ex-copular erection to occur.
Furthermore, evidence of the regional speciﬁcity of Kiss1 action
is supported by the observation that ICV administration of kp-
10 (0.1, 1, or 5–nmol) caused no sexual behavioral response, thus
demonstrating that the MePD may  be an obligatory structure for
the pro-erectile effect of Kiss1.
Kiss1 infusion into the MePD caused a dose-dependent increase
in plasma LH levels, as previously described for ovariectomized
rats [19]. Despite ICV kp-10 resulting in a comparable rise in cir-
culating levels of LH, only intra-MePD kp-10 evoked the erectile
response. It can be concluded that the plasma LH rise, and conse-
quently the Kiss1-induced GnRH secretion [20] is not related to the
observed Kiss1-induced erections, despite GnRH previously been
demonstrated to potentiate male sexual behavior [21]. Further to
this, LH is still high 30 min  post MePD infusion, but the erectile
response at this point has ceased. Additionally, the lack of effect of
intra-MePD administration of a Kiss1r antagonist on LH secretion,
which is not dissimilar to the effect of ICV administration of pep-
tide 234 in intact male rats and mice [22] supports the dissociation
between changes in plasma LH and erectile function.
Interestingly, male rats with no previous sexual experience
failed to respond to intra-MePD administration of kp-10 (data not
shown), which suggests a signiﬁcant context-dependent regula-
tion of ex-copular erections involving amygdala Kiss1 signalling.
The distinct mechanism by which Kiss1 signalling in the MePD
facilitates the erectile response is yet unclear. The MePD is sexu-
ally dimorphic with a greater volume, synaptic input and dendritic
spine density in male rats than in females, which is androgen
dependent [23]. Additionally, Kiss1 expression in the MePD is sexu-
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Fig. 3. Effect of kisspeptin or kisspeptin antagonist injection into the posterodorsal medial amygdala (MePD) on LH secretion in male rats. Representative LH proﬁles
demonstrating the effect of bilateral intra-MePD administration (↓) of vehicle (artiﬁcial cerebrospinal ﬂuid; aCSF) (A), kisspeptin-10 (kp-10, 0.1 nmol) (B), kp-10 (1 nmol)
(C),  or kisspeptin receptor antagonist (P-234, 5 nmol) (D) on LH secretion. Direct administration of kp-10 into the amygdala dose-dependently increases LH secretion (B,
C)  shown by increased area under curve (AUC) of the LH proﬁle (E). Kisspeptin antagonist had no effect on LH secretion (D, E). *p < 0.05, compared with vehicle. #p < 0.05,
compared with dose of 0.1 nmol kp-10 at same time point; n = 4–6 per group. Data presesented as mean and SEM.
ally dimorphic, with males having more Kiss1-expressing neurons,
reﬂecting activational effects of the prevailing androgenic milieu
[10]. Previous studies have shown that the exposure to female
vaginal secretions can increase Fos expression in the MePD of
male mandarin voles [24], and exposure to physically inaccessi-
ble females can selectively activate vasopressin neurons in the
MePD of male rats [25]. Since MePD Kiss1 neurons receive putative
innervation by vasopressinergic neurones [26], these observation
suggest that MePD Kiss1 neurons may  receive pheromonal cues
controlling sexual behavior. Indeed, projections from the accessory
olfactory bulb, which conveys pheromonal cues, densely innervates
the MePD [27], and recently these projections were also shown to
form close appositions to Kiss1 neurons in the MePD [26]. In addi-
tion to intrinsic vasopressin and Kiss1 interactions in the MePD,
GABA signalling plays a role in sexual behavior [28,29]. Intraperi-
toneal (IP) injection of a GABAA agonist decreases sexual behavior;
however, ex-copula erections were not speciﬁcally measured. IP
injection of the GABAB agonist, baclofen decreases sexual behavior
almost totally [28]. Subcutaneous injection of baclofen inhibits ex-
copula penile erections. However, mating can be achieved, so the
inhibition can be overridden [29]. However, when GABAB receptor
is knocked out in mice, Kiss1 mRNA increases in the MePD [30],
suggesting that GABAB regulates Kiss1 expression in the amygdala.
This supports the hypothesis that a decrease in GABAB receptor
allows an increase in Kiss1 and an increase in sexual behavior. By
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infusing kp-10 into the MePD the GABA inhibition on Kiss1 has been
potentially overridden causing erections.
In conclusion, Kiss1 infused into the MePD or ICV caused an
increase in LH. However, only infusion into the MePD causes ex-
copula erections, which can be analogised to a human erotica
erection. We conclude that Kiss1 has a role in male sexual behavior,
which is speciﬁc to the MePD, in addition to the regulatory function
on gonadotropic hormone secretion.
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